rifampicin-resistant TB

临床试验

计划入组 100 人 · 首次发布于 2024 年 7 月 29 日

尚未招募

PACTR202012756409365

Clofazimine and moxifloxacin PK, safety, and AccepTAbiLitY for paediatric TB treatment (CATALYST)

计划入组 36 人

招募中

NCT05081401

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

计划入组 1,050 人 · 首次发布于 2021 年 10 月 18 日

药物

查看全部 244 →

Small Molecule

Approved

Rifampicin(Isonarif, Rifadin, Rifamate, Rifater, Rofact)

相关疾病：Cholestatic pruritus, MRSA Infections，另有 4 项

C₄₃H₅₈N₄O₁₂ · Rx

rifampicin + isoniazid

rifampicin + trimethoprim

机构

查看全部 13 →

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC INCORPORATED IN THE STATE OF DELAWARE USA

South Africa

Global Alliance for TB Drug Development

United States

FREUNDESKREIS FUR INTERNATIONALE TUBERKULOSEHILFE E.V (FIT)

Vietnam

资讯

查看全部 2972 →

去年

Shorter Bedaquiline Regimens Show Sustained Efficacy Against Rifampicin-Resistant TB

去年

BioVersys Announces IPO to Fund Phase 3 Trials for BV100 and Alpibectir

去年

临床试验

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Clofazimine and moxifloxacin PK, safety, and AccepTAbiLitY for paediatric TB treatment (CATALYST)

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

药物

Rifampicin(Isonarif, Rifadin, Rifamate, Rifater, Rofact)

rifampicin + isoniazid

rifampicin + trimethoprim

机构

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC INCORPORATED IN THE STATE OF DELAWARE USA

Global Alliance for TB Drug Development

FREUNDESKREIS FUR INTERNATIONALE TUBERKULOSEHILFE E.V (FIT)

资讯

Shorter Bedaquiline Regimens Show Sustained Efficacy Against Rifampicin-Resistant TB

BioVersys Announces IPO to Fund Phase 3 Trials for BV100 and Alpibectir

Levofloxacin Shows Promise in Preventing Drug-Resistant TB in Household Contacts